Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
AMG 416
.
Show all posts
Showing posts with label
AMG 416
.
Show all posts
Wednesday, September 9, 2015
Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients
›
Amgen announced THE pooled data from two pivotal Phase 3, global, randomized, placebo-controlled trials evaluating AMG 416, a novel ...
›
Home
View web version
